COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin study #52 of 63
1/16 Early treatment study
Asghar et al., NCT04392713 (Preprint)
Efficacy of Ivermectin in COVID-19
Source   PDF   Share   Tweet
RCT with 103 patients in Pakistan comparing ivermectin and CQ, showing significantly lower PCR+ at day 7 with ivermectin. Results from [1].

Asghar et al., 1/16/2021, Randomized Controlled Trial, Pakistan, South Asia, preprint, 1 author, dosage 200μg/kg days 1, 8.
risk of no virological cure, 82.1% lower, RR 0.18, p < 0.001, treatment 50, control 50, day 7.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit